NASDAQ:AKBA   Akebia Therapeutics, Inc
Weekly Demand Zone
Entry 2.47
Stop 1.9
Target 5

Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
Trade active: Buy 2022 Jan C2.5/5 0.45 x4
No stop
Max RRR 4:1